Introduction
Pediatric seizures are a common problem. A large proportion of all pediatric seizures occur among children younger than 2 years of age 1, 2 where seizures tend to be of shorter duration and in more than 50% have focal features. [3] [4] [5] [6] Previous literature suggests that nearly half of children presenting with seizure having focal manifestations will have abnormal neuroimaging. While useful to help identify seizure etiology few of these findings lead to an acute change in management. 6, 7 Clinicians must determine whether to perform neuroimaging urgently with CT or MR or whether imaging can be done electively or not at all. The focus of this paper will be on the rate of neuroimaging findings that can be expected to result in an acute change in management or what we describe as clinically urgent intra-cranial pathology and whether current imaging recommendations can be refined. In 2009, the international League Against Epilepsy (ILAE) published imaging guidelines for new onset epilepsy, 8 offering a five point scale classification of neuroimaging findings, presented in Table 1 . While not aimed at first time seizure per se, this neuroimaging classification is relevant to assessing the results of emergent imaging Young children appear more likely to have findings on emergent neuroimaging that will alter the acute medical or surgical management, 5, 9 with one study reporting a prevalence of 17% among children younger than 33 months 9 compared to an estimated 2-4% overall.
Seizure 23 (2014) [740] [741] [742] [743] [744] [745] Guidelines regarding neuro-imaging for the evaluation of a child with a first episode of non-febrile seizure have also been published by the American Academy of Neurology (AAN), the Child Neurology Society (CNS), and the American Epilepsy Society (AES). 10 These guidelines call for emergent neuroimaging for children with persistent post-ictal neurologic deficit and children that are not back to baseline neurologic status within a few hours. Children with focal manifestations and age <1 year are candidates for non-emergent MR neuroimaging. 10 We sought to identify a selected group of children over 1 month of age presenting with a first-time non-febrile seizure with focal manifestations that would most benefit from emergent neuroimaging while also determining the prevalence of clinically urgent intra-cranial pathology among these children.
Methods

Study design and setting
This is a cross sectional study of all patients 1 month to 18 years of age presenting to an urban pediatric tertiary care ED between October 1995 and March 2012 with a first-time non-febrile seizure with focal manifestations. This ED serves approximately 55,000 children per year. The study was approved by the hospital institutional review board.
Patient identification
Patient identification was performed using a computer assisted screening tool using regular expressions. 11 This technique is similar to key word search tools, but provides a more comprehensive search allowing inclusion of possible misspelled and mistyped variations of the key words of interest. This was followed by manual chart review of patients identified by the screening tool. The authors have previously utilized this method to significantly enhance case detection compared to the use of ICD-9 coding.
12-14
Patient population
We included all children evaluated in the ED with a first-time non-febrile seizure with focal manifestations, who underwent neuroimaging within 24 h of ED presentation. We excluded children with altered mental status, acute trauma, inability to assess focal neurologic signs (e.g., intubated patients or preexisting hemiparesis), or a pre-existing and known neurologic abnormality such as structural brain abnormalities (preexisting tumor, stroke, hydrocephalus, arterio venous malformation [AVM] , presence of a ventriculo-pertoneal [VP] shunt, tuberous sclerosis).
Focal manifestations were defined as any recorded transitory disturbance in motor function with focality such as eye deviation, head tilt, or isolated limb twitching. Patients were also considered to have focal manifestations if a Todd's paresis was noted following what would otherwise have appeared to be a generalized seizure. Focal manifestations, number and duration of seizure(s) were based on history in the medical record from any witnesses.
Data collection
The review followed the principles described by Gilbert et al. 15 including selection of participants, definition of variables, use of abstract forms to train data abstractors (all physicians), meeting regularly to assess disagreements and disputes and assessment of inter-reviewer agreement rates. Two study investigators (N.A. and A.K.) reviewed the complete hospital medical records from the time of index visit to the time of chart review for all study patients. The following factors were abstracted: age, gender, prior history of seizures, seizure characteristics, neurologic examination findings, radiologic results, seizure management and ED disposition. Laboratory databases were reviewed for laboratory studies including chemistries, toxicology studies and cerebrospinal fluid studies if performed. Records were also screened for delayed imaging results (obtained greater than 24 h after presentation) and outpatient follow up with a neurologist. In cases where clinician records differed, we abstracted data from the documentation of the most senior clinician. Findings were considered missing if not documented by any treating clinician.
Classification of neuro-imaging studies
A single neuro-radiologist (SPP), blinded to clinical history and patient outcome, reviewed all neuroimaging studies (cranial computed tomography or magnetic resonance imaging) performed within 72 h of initial presentation to the study site ED. The study radiologist's interpretation was used for all analyses.
Outcome measure
Our primary outcome was clinically urgent intracranial pathology on neuroimaging defined as any finding likely to result in a medical or surgical intervention. These findings include: any mass lesion causing mass effect, infarction, hemorrhage, arterio-venous malformation (AVM), hydrocephalus, abscess, or acute disseminated encephalomyelitis (ADEM). Our outcome measure corresponds with level 5 of the ILAE scale (Table 1) .
Findings such as mild ventricular asymmetry, suspected preexisting hydrocephalus, small non-obstructive tumors, or an increase in the extra-axial fluid space were not considered urgent neuroimaging intracranial pathology. The finding a structural abnormality without mass effect may result in the use of an antiepileptic medication but this was not considered an emergent change in management.
Kappa analysis for clinical predictors
A pediatric neurologist (AT) reviewed the medical records of a randomly selected 15% of the study patients and abstracted clinical data. For each candidate predictor, we calculated both percent agreement and the kappa statistic to assess inter-rater reliability of candidate predictor. 16 We considered clinical predictors with a lower end of the 95% confidence interval (CI > 0.4) to have moderate agreement.
Statistical analysis
Candidate clinical predictors were evaluated for their potential correlation with the eventual abnormality on neuroimaging. We performed univariate analysis using x 2 analysis for categorical data and Mann-Whitney U test for continuous data.
We conducted a secondary analysis on patients who had no criteria for emergent imaging per current guidelines (e.g., no Todd's paresis). We used the Statistical Program for the Social Sciences (IBM SPSS Statistic Version 21, IMB Inc., Chicago, IL).
Results
Three hundred nineteen children met inclusion criteria for first time non-febrile seizure with focal manifestations and imaging within 24 h of presentation. See Fig. 1 for case identification.
The median patient age was 4.6 years [IQR 1.8-9.4] and 143 (45%) were females. One hundred seventy-eight children (56%) were admitted to the hospital. All patients (n = 319) had initial neuroimaging studies performed while in the ED. The emergent neuroimaging modality utilized was as follows: 262 children had a CT scan, 42 patients had both a CT and MR, and 15 had MR alone during the initial visit. One hundred sixty-three (62%) had a Fig. 1 . Case identification.
subsequent MR done within our institution of which 33% were done within 72 h of presentation. The median time to follow-up MR was 11 days [IQR 2-46]. One hundred forty-five children (46%) were transferred to our ED from another facility of which 110 (76%) had a brain CT prior to transfer.
Thirteen of the 319 children had a finding of clinically urgent intracranial pathology (4.1%; 95% CI: 2.2, 7.0). Hemorrhage and infarction were most common (5 and 4 cases, respectively). One patient had clinically urgent intra-cranial pathology on a subsequent MR that was not identified on CT. The prevalence of clinically urgent intracranial pathology was the same among patients presenting primarily to our facility (7/174; 4%; 95% CI: 1.8, 10) as seen among those seen initially at an outside facility (6/145; 4.1%; 95% CI: 1.7, 9.2%).
Brief summaries of patient presentations for those with significant urgent neuroimaging findings are presented in Table 2 .
Patient characteristics with and without clinically urgent intracranial pathology are presented in Table 3 . A sub-analysis excluding patients with Todd's paresis is presented in the bottom portion of the table. Fig. 2 presents a 2 Â 2 table for applying existing imaging guidelines and adding an age <18 months as part of imaging recommendation.
Results of delayed non-emergent MR neuroimaging
Two hundred five children of 252 who had CT scan for their urgent imaging, had a subsequent MR. Of these, 58/205 (28.2%) had abnormal findings on neuro-imaging. Using the ILAE imaging classification, one patient (0.5%) had a category 5 finding, nine patients (4.4%) level 4, 18 patients (8.8%) each in levels 3 and 2, and 12 patients (5.8%) were category 1. Of these 58 patients with findings 17 (29%) were not seen on the initial CT including one patient with a category 5 finding (which was of non-symmetric subcortical white matter signal abnormalities predominantly in the bilateral frontal lobes with leptomeningeal enhancement later confirmed by LP to be meningo-encephalitis).
Discussion
We present a large retrospective cohort of children with first time non-febrile seizure with focal manifestations for whom imaging could be done urgently or non-urgently by existing guidelines. In our cohort, the proportion of children with clinically urgent intracranial pathology (4.1%) was lower than previously reported. 5, 9 Further we confirm that children less than 18 months of age and those with Todd's paresis may be at higher risk of having clinically urgent intra-cranial pathology. Two large prior studies describe a higher prevalence of clinically urgent intra-cranial pathology among similar children. These studies included neuroimaging findings matching an ILAE category of 4 or 5, whereas for the objective to specifically determine which patients benefit from emergent imaging we include only those which most closely match to a category 5 finding. For example, brain mass with no associated hydrocephalus or mass effect was not considered to require emergent intervention in our cohort. Despite the difference in definitions it is useful to note that Garvey et al. performed a retrospective analysis of children who presented with a first time seizure 17 with a subset of 37 children for whom the seizure had documented focal onset. CT scan abnormalities were identified in 11 (37%) of these children with findings requiring intervention in 5 (13.5%). Sharma et al. reviewed children with new onset seizure of whom 133 presented with documented focal features. 9 Seventeen patients (13%) had imaging findings that lead to a change in management. Current imaging guidelines aimed at first time non-febrile seizures do not distinguish those presenting with focal and nonfocal manifestations. These guidelines have identified persistent 19 and others that children with focal neurologic deficits that do not return to baseline within a few hours are at significantly increased risk of having a significant emergent neuroimaging finding. Unfortunately this finding has poor sensitivity as the presence of Todd's paresis will not identify 70% of the cases with clinically urgent intra-cranial pathology seen in our cohort. We recommend adding age less than 18 months as an additional indication for emergent imaging as this resulted in the identification of an additional 40% of the cases in our cohort. Our data identify children less than 18 months of age to have an 8% risk of clinically urgent intracranial pathology compared to 4% overall. Young age has previously been associated with seizure focal manifestations 20 and high rates of imaging findings. 5 Sharma Our study has several important limitations. First, our study was retrospective and the predictors were assessed by medical chart review. We attempted to minimize this potential bias by selecting objective parameters that would be recorded accurately in the medical chart with good inter-rater reliability for inclusion. Second, while our overall rate of significant emergent neuroimaging findings of 4.1% is lower than previously reported we believe we may overestimate the risk because we included only patients who were imaged. Third, seizure focality may be under reported by parents, bystander witnesses and clinicians and there is data suggesting inter-observer agreement on focal manifestations may be poor. 2 In addition focality is so common in infants that Korff et al. 20 titled their manuscript ''Do generalized tonic-clonic seizures in infancy exist?''. There is however data supporting the value of focality as a predictor in young children: Sharma et al. 9 showed a clear difference in imaging yield between children with generalized seizure on presentation and infants and toddlers with focal features. Finally, despite the large number of patient in our study the number with urgent neuroimaging findings was too small to generate a multivariate model and a robust prediction rule. A larger study may allow further risk stratification for children and allow age-based subgroup analysis.
Conclusion
We identified a large retrospective cohort of children with first time non-febrile seizure with focal manifestations evaluated in the ED of a single center over an 18-year period with a 4% prevalence of clinically urgent intracranial pathology. Based on our data we suggest children less than 18 months should be considered for addition to imaging guidelines as an indication for emergent neuroimaging.
